Cellular Immunotherapy of Canine Cancer
Infusions with immune cells, such as lymphocytes or natural killer (NK) cells, represent one of several modalities of immunotherapy. In human patients with advanced B-cell leukemia or lymphoma, infusions with chimeric antigen receptor (CAR) T-lymphocytes have shown promising responses. However, the...
Main Authors: | Selamawit Addissie, Hans Klingemann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/5/4/100 |
Similar Items
-
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
by: Rohtesh S. Mehta, et al.
Published: (2018-02-01) -
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
by: Ahmet Yilmaz, et al.
Published: (2020-12-01) -
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
by: Aline Pfefferle, et al.
Published: (2020-03-01) -
Immunotherapy for Dogs: Still Running Behind Humans
by: Hans Klingemann
Published: (2021-08-01) -
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
by: Olaf Oberschmidt, et al.
Published: (2017-06-01)